课题基金 / 基金详情

T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis

T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
人复发性扁桃体炎中滤泡辅助性 T (Tfh) CD4 T 细胞、生发中心和抗体反应功能障碍
批准号:
10169568
负责人:
Shane P Crotty
金额:
$38.62万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-26 至 2021-02-28

项目摘要

项目成果

Shane P Crotty的其他基金

相似基金

相关文献

中文摘要
翻译
整体组件 COVID19是一种严重的持续大流行。我们对这种疾病的免疫反应缺乏了解, 这既损害了适当疗法的发展,也损害了疫苗的开发。疫苗是成本最高的疫苗之一 有效且非常成功的医疗干预。这些疫苗大多依赖于CD4T+细胞 以及他们对B细胞的帮助。在过去的一段时间里,我们开发了多种新技术来研究人类的CD4+T细胞 几年来,一直在我们的LJI CCHI实施。这里提出的补充建议将有助于 快速和积极地了解人类对SARS-CoV2的T细胞反应,这可能是 帮助开发柯萨奇病毒19的治疗方法和疫苗。
英文摘要
Overall Component COVID19 is a severe ongoing pandemic. Our understanding of the immune response to this disease is lacking, which impairs both the development of proper therapeutics and a vaccine. Vaccines are one of the most cost effective and extraordinarily successful medical interventions. Most of those vaccines depend on CD4 T+ cells and their help to B cells. We have developed multiple new techniques to study human CD4+ T cells over the past several years, which have have been implementing in our LJI CCHI. The supplement proposed here will facilitate rapid and vigorous pursuit of an understanding of the T cell responses to SARS-CoV2 in humans, which may help in the development of treatments and vaccines for COVID19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune engineering of optimized sequential immunization strategies for HIV vaccines
Immune engineering of optimized sequential immunization strategies for HIV vaccines
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
  • 批准号:
    10304742
  • 项目类别:
  • 资助金额:
    $126.39万
  • 财政年份:
    2020
  • 负责人:
    Shane P Crotty
  • 依托单位:
Administrative Core
  • 批准号:
    10591866
  • 项目类别:
  • 资助金额:
    $6.88万
  • 财政年份:
    2020
  • 负责人:
    Shane P Crotty
  • 依托单位:
海外基金